Eptifibatide and Sertraline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordEptifibatide
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What's going on: Sertraline is an antidepressant, and eptifibatide is a strong 'blood thinner' (an antiplatelet) usually given in the hospital during heart procedures. Both can make it harder for your blood to clot. Sertraline does this because it affects a chemical called serotonin that your platelets use to help form clots. When you use them together, the effect can add up, so you may bruise or bleed more easily.
The good news is that this is well understood, and your care team knows how to watch for it. Since eptifibatide is given in a monitored setting, your team can keep a close eye on you and manage this. Just let them know about any unusual bruising, nosebleeds, or bleeding that won't stop.
Effect: Additive risk of bleeding when sertraline (SSRI) is combined with eptifibatide (GP IIb/IIIa inhibitor antiplatelet).
Mechanism: Pharmacodynamic. SSRIs deplete platelet serotonin, impairing serotonin-mediated platelet aggregation; combined with eptifibatide's direct inhibition of platelet aggregation, hemostasis is further compromised. Neither agent is metabolically dependent on the other (no PK component).
Evidence: Theoretical/observational; case-control and cohort data link SSRIs plus antiplatelets to increased bleeding. Onset unspecified. Severity: major.
- Monitor for epistaxis, ecchymosis, hematoma, petechiae, and signs of major hemorrhage.
- Eptifibatide is typically administered in a monitored inpatient setting; weigh bleeding risk against indication.
- Counsel patient on bleeding signs.
What happens
An increased risk of bleeding
Interaction Deep Dive
Caution is warranted when a SSRI is given together with an antiplatelet agent, since the combination may heighten the likelihood of bleeding events32. Using sertraline alongside an antiplatelet may amplify bleeding risk, an effect potentially attributable to the influence of sertraline on serotonin release from platelets. Both case-control and cohort studies have demonstrated that concurrent use of selective serotonin and norepinephrine reuptake inhibitors (for example, sertraline) with antiplatelet agents carries an elevated bleeding risk. The bleeding events that have been documented include epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening. During simultaneous administration of sertraline and an antiplatelet agent, watch the patient for indications of heightened bleeding and advise patients about the greater bleeding risk1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
Keep taking both as prescribed. Eptifibatide is given in a hospital or cath-lab setting, so your team is already watching you closely, and they can manage this combination.
- Your care team will monitor you for signs of increased bleeding while both are used.
- Tell staff right away about nosebleeds, unusual bruising, blood in urine or stool, or any bleeding that won't stop.
- Do not stop your sertraline on your own; let your prescriber decide any changes.
- If you have questions, raise them with your pharmacist or doctor.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
3 reports — tap to read
a) A retrospective study involving patients older than 50 years diagnosed with acute myocardial infarction (N=27,058) found that combining an SSRI with any antiplatelet therapy significantly raised the bleeding risk by 1.42-fold relative to aspirin alone. The combination of aspirin, clopidogrel, and an SSRI significantly elevated risk by 2.35-fold compared with aspirin alone and by 1.57-fold compared with combined clopidogrel and aspirin therapy 2.
b) A systematic review and meta-analysis encompassing 22 observational studies found that SSRI use correlated with a significant 1.55-fold rise in the risk of upper gastrointestinal bleeding (UGIB). The simultaneous use of SSRIs and antiplatelet agents was linked to a 2.48-fold increase in UGIB risk (3 studies) 3.
c) Both case reports and epidemiological investigations (case-control and cohort studies) have shown a link between agents that impair serotonin reuptake and the occurrence of gastrointestinal bleeding. According to data from published observational studies, SSRI exposure, especially during the month prior to delivery, has been linked to a less than 2-fold rise in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have spanned from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Eptifibatide and Sertraline together?
Combining sertraline with eptifibatide can add to your bleeding risk, so your care team will monitor you closely and you should report any unusual bleeding or bruising right away. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Eptifibatide and Sertraline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Eptifibatide and Sertraline interaction managed?
Keep taking both as prescribed. Eptifibatide is given in a hospital or cath-lab setting, so your team is already watching you closely, and they can manage this combination. Your care team will monitor you for signs of increased bleeding while both are used. Tell staff right away about nosebleeds, unusual bruising, blood in urine or stool, or any bleeding that won't stop. Do not stop your sertralin… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Eptifibatide or Sertraline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Labos C, Dasgupta K, Nedjar H, et al: Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011; 183(16):1835-1843. PubMed
- Jiang HY, Chen HZ, Hu XJ, et al: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13(1):42-50. PubMed
Keep reading about Sertraline
Keep reading about Eptifibatide
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist